05/02/2024 6:31 AM | BridgeBio Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/06/2024 4:13 PM | BridgeBio Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/06/2024 4:15 PM | BridgeBio Pharma (Filer)
| Form 424B5 | |
03/04/2024 6:00 AM | BridgeBio Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/22/2024 6:31 AM | BridgeBio Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/16/2024 6:15 PM | BridgeBio Pharma (Subject) Kumar Neil (Filed by)
| Form SC 13G/A | |
01/29/2024 4:25 PM | BlackRock Inc. (Filed by) BridgeBio Pharma (Subject)
| Form SC 13G/A | |
|
01/23/2024 9:16 AM | BridgeBio Pharma (Subject) STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/18/2024 3:10 PM | BridgeBio Pharma (Issuer) Valantine Hannah (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/18/2024 6:30 AM | BridgeBio Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/08/2024 4:14 PM | BridgeBio Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/26/2023 4:33 PM | BridgeBio Pharma (Subject) MCCORMICK FRANK (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/18/2023 3:15 PM | BridgeBio Pharma (Subject) Scott Randal W. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/01/2023 3:20 PM | BridgeBio Pharma (Subject) Scott Randal W. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/22/2023 3:15 PM | BridgeBio Pharma (Subject) VIKING GLOBAL INVESTORS LP (Filed by)
| Form SC 13D/A | |
11/17/2023 3:27 PM | BridgeBio Pharma (Subject) Kumar Neil (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/17/2023 3:27 PM | BridgeBio Pharma (Subject) STEPHENSON BRIAN C (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/15/2023 3:03 PM | BridgeBio Pharma (Subject) Valantine Hannah (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/02/2023 6:31 AM | BridgeBio Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/25/2023 3:00 PM | BridgeBio Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/07/2023 3:00 PM | BridgeBio Pharma (Issuer) Scott Randal W. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/05/2023 3:14 PM | BridgeBio Pharma (Subject) Scott Randal W. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/03/2023 3:12 PM | BridgeBio Pharma (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/03/2023 6:32 AM | BridgeBio Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/19/2023 8:52 PM | BridgeBio Pharma (Subject) VIKING GLOBAL INVESTORS LP (Filed by)
| Form SC 13D/A | |
07/19/2023 8:33 PM | BridgeBio Pharma (Issuer) HALVORSEN OLE ANDREAS (Reporting) Ott David C. (Reporting) Shabet Rose Sharon (Reporting) VIKING GLOBAL INVESTORS LP (Reporting) Viking Global Opportunities GP LLC (Reporting) Viking Global Opportunities Illiquid Investments Sub-Master LP (Reporting) Viking Global Opportunities Parent GP LLC (Reporting) Viking Global Opportunities Portfolio GP LLC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/18/2023 8:31 PM | BridgeBio Pharma (Subject) Viking Global Opportunities Illiquid Investments Sub-Master LP (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/17/2023 6:23 AM | BridgeBio Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/23/2023 3:17 PM | BridgeBio Pharma (Issuer) DANIELS RONALD J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2023 3:18 PM | BridgeBio Pharma (Issuer) Ellis Andrea (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2023 3:19 PM | BridgeBio Pharma (Issuer) Hassan Fred (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2023 3:20 PM | BridgeBio Pharma (Issuer) HOMCY CHARLES J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2023 3:21 PM | BridgeBio Pharma (Issuer) Lo Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2023 3:22 PM | BridgeBio Pharma (Issuer) MOMTAZEE JAMES C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2023 3:23 PM | BridgeBio Pharma (Issuer) Satvat Ali J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2023 3:24 PM | BridgeBio Pharma (Issuer) Scott Randal W. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2023 3:25 PM | BridgeBio Pharma (Issuer) Valantine Hannah (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2023 3:14 PM | AGUIAR ERIC (Reporting) BridgeBio Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/22/2023 3:05 PM | BridgeBio Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/17/2023 3:46 PM | BridgeBio Pharma (Subject) STEPHENSON BRIAN C (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/17/2023 3:48 PM | BridgeBio Pharma (Subject) Kumar Neil (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
Incredible Opportunity to Retire FAST! (Ad) A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market. Click here to get instant access to the guide |